Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
J Tissue Eng Regen Med ; 4(4): 284-90, 2010 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-19967748

RESUMO

The c-myc oncogene has been shown to be overexpressed in a number of malignancies and plays a key role in the abnormal growth regulation of melanoma cells. This study aimed to provide an efficient system for the in vitro manipulation of c-myc expression by antisense oligonucleotides. Therefore, we used poly(NIPA)/PEI2B copolymer as vector in order to improve the intracellular availability and stability of AS ODNs. We targeted oligonucleotide sequences within the human c-myc mRNA as free AS ODNs or conjugated with a thermosensitive copolymer, in an effort to inhibit the growth of human melanoma cells. The conjugates adopted more positive charge and smaller size at 37 degrees C and they had no toxic effects on human fibroblast cells. The conjugated AS ODNs showed increased antiproliferative effect on melanoma cells as compared to free AS ODNs. At a concentration of 100 ng, AS ODNs inhibited SK-MEL 30 human melanoma cell line proliferation maximally by 18.6%, whereas the same amount of conjugated AS ODN provided 52% inhibition. The greatest inhibition was obtained by conjugates having a polymer:AS ODN ratio of 9. Greatest inhibition was detected at 48 h and decreased after 96 h, which may be due to the depletion of AS ODNs. The results confirm the enhanced antiproliferative effects of poly(NIPA)/PEI2B-conjugated AS ODNs, which may provide improved intracellular availability for c-myc-directed antisense strategies.


Assuntos
Resinas Acrílicas , Portadores de Fármacos , Melanoma/patologia , Oligonucleotídeos Antissenso/farmacologia , Polietilenoimina/análogos & derivados , Proteínas Proto-Oncogênicas c-myc/genética , Morte Celular/efeitos dos fármacos , Linhagem Celular Tumoral , Proliferação de Células/efeitos dos fármacos , Humanos , Melanoma/genética , Melanoma/metabolismo , Melanoma/terapia , Tamanho da Partícula , Proteínas Proto-Oncogênicas c-myc/biossíntese , Temperatura
2.
J Pharm Sci ; 78(6): 460-1, 1989 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-2788215

RESUMO

Analgesic and anti-inflammatory effects of N-(p-ethoxyphenyl)-2,6-dihydroxybenzamide (1), N-(p-ethoxyphenyl)-2,6-diacetoxybenzamide (2), N-(p-ethoxyphenyl)-2,5-dihydroxybenzamide (3), and N-(p-ethoxyphenyl)-2,5-diacetoxybenzamide (4) have been investigated in mice and rats. The analgesic effect of 2 on acetic acid-induced writhing was found to be stronger than that of aspirin, whereas that of 1, 3, and 4 was weaker than that of aspirin. In inflammatory studies, 1-4 showed inhibition of formaldehyde-induced paw swelling (edema). The effects of 1-3 were more potent than that of aspirin, 1 being the most potent. The potency of 4 was almost equal to that of aspirin.


Assuntos
Anilidas/farmacologia , Anti-Inflamatórios não Esteroides/farmacologia , Anilidas/farmacocinética , Animais , Anti-Inflamatórios não Esteroides/farmacocinética , Disponibilidade Biológica , Masculino , Camundongos , Ratos , Relação Estrutura-Atividade
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA